Evidence map›Paper›PMID 35356687›Full record

ReviewACS omega2022

Progress in Niobium Oxide-Containing Coatings for Biomedical Applications: A Critical Review.

Mir Saman Safavi, F C Walsh, Livia Visai, Jafar Khalil-Allafi

Abstract readReview
In one paragraph

Review in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Impact of NbACS omega · 2026
    Article
  4. Synergistic potential of antibiotics against anFrontiers in bioengineering and biotechnology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mir Saman SafaviResearch Center for Advanced Materials, Faculty of Materials Engineering, Sahand University of Technology, 513351996 Tabriz, Iran.
F C WalshElectrochemical Engineering Laboratory & National Centre for Advanced Tribology, Faculty of Engineering and the Environment, University of Southampton, Southampton SO17 1BJ, U.K.
Livia VisaiMolecular Medicine Department (DMM), Center for Health Technologies (CHT), UdR INSTM, University of Pavia, Via Taramelli 3/B, 27100 Pavia, Italy.ORCID https://orcid.org/0000-0003-1181-3632
Jafar Khalil-AllafiResearch Center for Advanced Materials, Faculty of Materials Engineering, Sahand University of Technology, 513351996 Tabriz, Iran.ORCID https://orcid.org/0000-0002-3291-753X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Typically, pure niobium oxide coatings are deposited on metallic substrates, such as commercially pure Ti, Ti6Al4 V alloys, stainless steels, niobium, TiNb alloy, and Mg alloys using techniques such as sputter deposition, sol-gel deposition, anodizing, and wet plasma electrolytic oxidation. The relative advantages and limitations of these coating techniques are considered, with particular emphasis on biomedical applications. The properties of a wide range of pure and modified niobium oxide coatings are illustrated, including their thickness, morphology, microstructure, elemental composition, phase composition, surface roughness and hardness. The corrosion resistance, tribological characteristics and cell viability/proliferation of the coatings are illustrated using data from electrochemical, wear resistance and biological cell culture measurements. Critical R&D needs for the development of improved future niobium oxide coatings, in the laboratory and in practice, are highlighted.

Identifiers

PMID35356687
PMCPMC8944537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.